Audrey Benyamine, A. Le Roy, Emilie Mamessier, J. Gertner-Dardenne, C. Castanier, et al.. BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia..
OncoImmunology, Taylor & Francis, 2016,
⟨10.1080/2162402X.2016.1146843⟩.
⟨inserm-01416288⟩